Overview

5-fluorouracil for Treatment of Stable Vitiligo

Status:
COMPLETED
Trial end date:
2024-04-15
Target enrollment:
Participant gender:
Summary
Vitiligo, a significant dermatologic challenge affecting 0.5 to 2% of the global population. Despite various existing medical approaches, current vitiligo treatments are still far from optimal.
Phase:
NA
Details
Lead Sponsor:
Al-Azhar University
Treatments:
Fluorouracil
Sodium Chloride